Neuro Drugs Flashcards
1
Q
Dantrolene
A
- decreases muscle contraction by directly interfering with calcium ion release from sarcoplasmic reticulum in skeletal muscle
- uncoupled excitation-contraction process
- useful in treating malignant hyperthermia
2
Q
Baclofen
A
- GABA-B agonist
- used to treat spasticity, improve mobility in pts with MS
- works on spinal cord to block polysynaptic afferent pathways
- acts as inhibitory neurotransmitter or by hyperpolarizing the primary afferent nerve terminals which inhibit other excitatory neurotransmitters
- works at supraspinal sites
3
Q
Cyclobenzaprine
A
- similar to amitriptyline, effects are similar to tricyclic antidepressants
- sedation, confusion, visual hallucinations and releases histamine
- relieves muscle spasms through central action
- no direct action on NMJ or muscle
4
Q
Tizanidine
A
- central acting alpha2-adrenergic agonist acts pre and post synaptically within the cord
- related to clonidine
- decreases release of excitatory amino acids and inhibits spinal motor neurons
- drowsiness and sedation
- no muscle weakness
5
Q
Riluzole, Idrocilamide
A
- inhibits glutamate transmission and improves energy metabolism in muscles
- inhibits release of glutamate by interfering with sodium channels
- treats ALS and Huntington’s disease
- extends survival
- side effects: asthenia, decreased lung function, pneumonia, vertigo, parasthesia, anorexia, somnolence
6
Q
Gabapentin
A
- antiepileptic used for MS patients
- GABA analog works on Ca2+ receptors
7
Q
Progabide
A
-GABA-A and GABA-B agonist with active metabolites
8
Q
Morphine
A
- strong mu agonists
- chronic and severe pain
- high intrinsic activity
- hospice care, fixed-interval administration with regular dose
- low O/P ratio
- used for acute pulmonary edema, anxiety, decrease cardiac load
9
Q
Oxycodone
A
- chronic and severe pain
- high intrinsic activity
- hospice care, fixed-interval administration with regular dose
- strong mu agonist
- low O/P ratio
10
Q
Fentanyl
A
- strong mu agonist
- low O/P ratio
- transdermal patch given over long period if GI transit occurs from oral
- buccal for short, breakthrough pain
- low risk of respiratory depression so can be used for adjunct anesthesia
- decreases heart rate, increase ICP, caution in liver failure
11
Q
Methadone
A
- strong mu agonist
- high O/P ratio
- synthetic with equal potency to morphine
- maintenance in rehab programs, withdrawal less severe
- block NMDA receptors & monoaminergic reuptake transporters
- metabolized by CYP3A4&CYP2D6, thus liver dysfunction w/overdose
12
Q
Meperidine
A
- strong mu agonist
- medium O/P ratio
- synthetic with equal potency to morphine
- less severe resp depression, constipation, biliary colic,& urinary retention
- strong anti-muscarinic effects - tachycardia is contraindication
- renal failure can predispose accumulation of metabolite, normeperidine which can cause seizures
- used for shivering
13
Q
Codeine
A
- Full mu agonist
- high O/P ratio
- used for cough suppression
- often combined with other drugs (aspirin, acetaminophen)
- can antagonize strong agonists
14
Q
Hydrocodone
A
- partial mu agonist
- medium O/P ratio
- cough suppression
- often combined with other drugs
- can antagonize strong agonists
15
Q
Loperamide
A
- possibly good for peripheral neuropathic pain because of actions at mu opioid receptors while lacking CNS effects
- used for anti-diarrhea
16
Q
Tramadol
A
- very weak opioid agonist
- inhibits serotonin and norepinephrine reuptake
- useful to treat chronic pain
- avoid issues with tolerance
- decreases seizure threshold and risk for serotonin syndrome
17
Q
Buprenorphine
A
- kappa antagonist and partial mu agonist
- sublingual route is preferred to avoid 1st pass
- long acting, slow dissociation from mu receptors
- resistant to naloxone reversal
- added with Naloxone as a maintenance program for heroin addicts, as effective as methadone in detox from opioids
18
Q
Butorphanol
A
- kappa-opioid agonist and partial mu-opioid agonist
- causes withdrawal symptoms
- treats severe pain, greater sedation than buprenorphine
- not easily reversed with naloxone
19
Q
Dextromethorphan
A
- used for cough suppression
- free of addictive properties and leads to less constipation than codeine
20
Q
Isoflurane
A
- medium rate of onset and recovery, declining use
- potentiate GABA-A and glycine receptors, K+ channels
- inhibit glutamatergic ionotropic receptors and neuronal nicotinic AChR’s
- decreased peripheral resistance, decreased O2 consumption, resp depression, nausea/vomiting, decreased metabolic rate, increased cerebral flow and IC pressure, decrease blood flow
- can cause malignant hyperthermia
21
Q
Nitrous Oxide
A
- rapid rate of onset and recovery
- incomplete anesthetic, used as combo
- blocks NMDA receptor mediated synaptic transmission in spinal cord
- decrease myocardial function, increase sympathetic outputs, nausea/vomiting, increase cerebral flow and ICP, decrease blood flow
- may cause malignant hyperthermia, treat with dantrolene
22
Q
Midazolam
A
- benzo, facilitate GABA-A
- used as adjuncts prior to anesthesia to produce anxiolysis, amnesia, sedation
- water soluble, given IV, no venous irritation, rapid onset, shorter duration of action
23
Q
Thiopental
A
- barbs
- lipophilic agent that rapidly enters and depresses CNS
- ultra-short acting
- facilitates GABA-A
- used during induction of anesthesia and deep sedation
- decreases cerebral metabolism and blood flow (lowers ICP)
- nausea, vomiting, decreases CV resistance
24
Q
What are 4 good analgesics?
A
- Nitrous oxide
- Fentanyl
- Ketamine
- Dexmetomidine
25
Q
Propofol
A
- potentiates GABA-A receptors, used for induction and maintenance
- onset and recovery are rapid
- used often for conscious sedation
- resp depression, decrease peripheral resistance, decrease ICP, antiemetic
26
Q
Etomidate
A
- potentiates GABA-A receptor
- use for induction in pts with hypotension
- minimal resp depression, minimal CV depression, vomiting, pain with injection, myoclonus, decrease plasma levels of hydrocortisone
27
Q
Ketamine
A
- PCP analog, blocks NMDA receptors
- dissociative anesthesia, catatonia, amnesia and analgesia without loss of consciousness
- only IV that produces CV stimulation, minimal effects on resp, increases ICP
28
Q
Dexmetomidine
A
- short term sedation of intubated and ventilated ICU patients
- Alpha2-adrenergic receptor agonist
- analgesia produced by activation of these receptors in spinal cord
- hypnosis produced by activation of these receptors in locus coeruleus
- little effect on resp, decreases cerebral blood flow
29
Q
L-DOPA/Carbidopa (Sinemet)
A
- L-Dopa is precursor of dopamine, but can cross BBB
- Carbidopa enhances bioavailability of L-DOPA, prolongs 1/2 life
- causes nausea by stimulation of D2 receptors in area postrema, tachycardia, nightmares/hallucinations, may produce dyskinesia after long-term treatment
- contraindicated in: psychotic pts, pts with CV disease
30
Q
COMT inhibitors (Entacapone)
A
- inhibition of COMT enhances amount of L-dopa available for CNS, increases bioavailability
- blocks metabolism to 3-0-methyldopa